MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 157 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,865 | -58.4% | 3,043 | +7.8% | 0.00% | – |
Q2 2023 | $9,284 | +309366.7% | 2,822 | +362.6% | 0.00% | – |
Q1 2023 | $3 | -25.0% | 610 | 0.0% | 0.00% | – |
Q4 2022 | $4 | -99.9% | 610 | -11.8% | 0.00% | – |
Q3 2022 | $5,000 | +66.7% | 692 | +13.4% | 0.00% | – |
Q2 2022 | $3,000 | -98.5% | 610 | -98.7% | 0.00% | -100.0% |
Q1 2022 | $194,000 | +6366.7% | 48,710 | +7885.2% | 0.00% | – |
Q4 2021 | $3,000 | -50.0% | 610 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | -88.0% | 610 | -83.3% | 0.00% | – |
Q2 2021 | $50,000 | -67.5% | 3,660 | -61.5% | 0.00% | -100.0% |
Q1 2021 | $154,000 | -78.2% | 9,510 | -64.3% | 0.00% | -80.0% |
Q4 2020 | $708,000 | +420.6% | 26,610 | +264.0% | 0.01% | +400.0% |
Q3 2020 | $136,000 | -20.5% | 7,310 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $171,000 | – | 7,310 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |